Literature DB >> 8981622

The non-competitive NMDA antagonist MK-801 increases food intake in rats.

G A Burns1, R C Ritter.   

Abstract

A role for excitatory amino acids in the control of feeding behavior has not been extensively investigated. Nevertheless, there is direct and circumstantial evidence to indicate that some circuits involved with feeding behavior include glutamatergic elements. To test the hypothesis that endogenous glutamate participates in the control of food intake, we performed experiments to determine whether MK-801, a non-competitive N-methyl-D-aspartate (NMDA) ion channel antagonist, is capable of altering intake of liquid and solid foods in hungry or satiated rats. Following a 16 h fast, intake of 15% sucrose was significantly enhanced by systemic treatment with MK-801. Water intake was not altered by the NMDA antagonist. Rats did not ingest more rat chow after MK-801, unless they had been fasted. When a more palatable food (cookies) was offered, MK-801 did increase intake. Thus MK-801 enhanced food intake only when feeding was initiated by food-deprivation or increased palatability. In conclusion, our results support the hypothesis that endogenous glutamate plays a role in the control of food intake. Blockade of NMDA receptor function by MK-801 may diminish or delay satiety signals, rather than initiate feeding behavior per se.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8981622     DOI: 10.1016/S0091-3057(96)00171-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  17 in total

1.  Morphine and MK-801 administration leads to alternative N-methyl-D-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay.

Authors:  E M Anderson; A Y Del Valle-Pinero; S K Suckow; T A Nolan; J K Neubert; R M Caudle
Journal:  Neuroscience       Date:  2012-04-21       Impact factor: 3.590

2.  Vagotomy upregulates expression of the N-methyl-D-aspartate receptor NR2D subunit in the stomach.

Authors:  Kanako Watanabe; Takeshi Kanno; Tadayuki Oshima; Hiroto Miwa; Chikara Tashiro; Tomoyuki Nishizaki
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

3.  Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors.

Authors:  Jason Wright; Carlos Campos; Thiebaut Herzog; Mihai Covasa; Krzysztof Czaja; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-11       Impact factor: 3.619

4.  Role of ionotropic glutamate receptors in delay and probability discounting in the rat.

Authors:  Justin R Yates; Seth R Batten; Michael T Bardo; Joshua S Beckmann
Journal:  Psychopharmacology (Berl)       Date:  2014-10-02       Impact factor: 4.530

5.  NMDA receptors control vagal afferent excitability in the nucleus of the solitary tract.

Authors:  Katie M Vance; Richard C Rogers; Gerlinda E Hermann
Journal:  Brain Res       Date:  2014-11-15       Impact factor: 3.252

Review 6.  A tale of two endings: modulation of satiation by NMDA receptors on or near central and peripheral vagal afferent terminals.

Authors:  Robert C Ritter
Journal:  Physiol Behav       Date:  2011-03-05

Review 7.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18

8.  Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder.

Authors:  Adam Bisaga; Wojciech Danysz; Richard W Foltin
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-24       Impact factor: 4.600

9.  NR2B subunit of the NMDA glutamate receptor regulates appetite in the parabrachial nucleus.

Authors:  Qi Wu; Ruimao Zheng; Dollada Srisai; G Stanley McKnight; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-20       Impact factor: 11.205

10.  The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.

Authors:  Elizabeth G Mietlicki-Baase; Pavel I Ortinski; Laura E Rupprecht; Diana R Olivos; Amber L Alhadeff; R Christopher Pierce; Matthew R Hayes
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-08       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.